Beyond metabolic reprogramming, TFAM knockdown has also been shown to enhance migration and/or invasion in lung cancer cells [24], renal carcinoma cells [32], gastric cancer cells [34], head and neck cancer cells [35] and hepatocellular cells [36]. This evidence concerns the gene TFAM and lung carcinoma.